T2 Biosystems to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
November 08 2018 - 7:00AM
T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and
commercialization of innovative medical diagnostic products for
critical unmet needs in healthcare, announced today that John
McDonough, president and chief executive officer, is scheduled to
present at the Canaccord Genuity Medical Technologies &
Diagnostics Forum. The conference is being held on November 15 at
the Westin Grand Central in New York.
Mr. McDonough is scheduled to present on Thursday, November 15,
2018 at 11:00 a.m. ET. Mr. McDonough and John Sprague, chief
financial officer, will be available for one-on-one meetings during
the conference. The presentation will be webcast live and available
for replay, and may be accessed by visiting the Investors/Events
& Presentations section of the Company’s website at
www.t2biosystems.com. A replay of the webcast will be available
shortly after the conclusion of the presentation and will be
archived on the Company's website for 90 days following the
presentation.
About T2 Biosystems:T2 Biosystems, a leader in
the development and commercialization of innovative medical
diagnostic products for critical unmet needs in healthcare, is
dedicated to improving patient care and reducing the cost of care
by helping clinicians effectively treat patients faster than ever
before. T2 Biosystems’ products include the T2Dx® Instrument,
T2Candida® Panel, and T2Bacteria® Panel, and are powered by the
proprietary T2 Magnetic Resonance (T2MR®) technology. T2 Biosystems
has an active pipeline of future products, including products for
the detection of additional species and antibiotic resistance
markers of sepsis pathogens, and tests for Lyme disease. For more
information, please visit www.t2biosystems.com.
Media Contact: Gina Kent, Vault
Communicationsgkent@vaultcommunications.com610-455-2763
Investor Contact:Zack Kubow, W2O
Groupzkubow@w2ogroup.com415-946-1053
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Aug 2024 to Sep 2024
T2 Biosystems (NASDAQ:TTOO)
Historical Stock Chart
From Sep 2023 to Sep 2024